Home/SEC 13D/G/NSRXSEC 13D/GNSRX - Nasus Pharma Ltd. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks Simplified$NSRX$3.20βΌ -57.62% YTDHealthcareAug 14, 2026 Β· ThinkSabio BlogSEC Filing Update: #NSRX Nasus Pharma Ltd. : $3.20 Sector: Healthcare | YTD: π½ -57.62% The SEC disclosed Today (14-AUG-2026) that BALYASNY ASSET MANAGEMENT LLC has INCREASED #NSRX Shares by 30.21% π’ * Previous Holdings: 898.47K Shares * Current Holdings: 1.17M Shares * Increase+271.44K * Increased(%)+30.21% * Ownership: 9.99% * Estimated Investment Value: $901.17K https://www.thinksabio.com/reports/isr/NSRX Institutional ownership in #NSRX has been steadily rising over the past 2 quarters in Shares: Q4 2025: 2.38K Q1 2026: 2.17M Share this postπCopy Linkπ¬ Comments Loading commentsβ¦Leave a commentPost Commentβ All PostsMore SEC 13D/G